» Articles » PMID: 20061434

Identification and in Vitro Characterization of Follicle Stimulating Hormone (FSH) Receptor Variants Associated with Abnormal Ovarian Response to FSH

Overview
Specialty Endocrinology
Date 2010 Jan 12
PMID 20061434
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Context: FSH mediates cyclic follicle growth and development and is widely used for controlled ovarian stimulation in women undergoing infertility treatment. The ovarian response of women to FSH is variable, ranging from poor response to ovarian hyperstimulation.

Objective: We investigated whether genetic alterations of the FSH receptor (FSHR) contribute to this variability.

Design And Patients: Our approach was to study women undergoing treatment with in vitro fertilization falling into the edges of the normal distribution of ovarian response to FSH, with respect to age.

Setting: We conducted the study at the Yale Fertility Clinic.

Methods: We extracted RNA from cumulus cells surrounding the oocytes of women undergoing in vitro fertilization and analyzed the FSHR mRNA by RT-PCR and sequencing.

Results: We identified four abnormal FSHR splicing products (three exon deletions and one intron insertion) in the FSHR mRNA in 37% (13 of 35) of women tested. All alterations affected the extracellular ligand-binding portion of the receptor without causing a frameshift. When transfected in HEK293T cells, all four splicing variants showed markedly decreased cAMP activation compared to controls. Untransfected cells showed no response to FSH, whereas all the cell lines showed normal cAMP activation when treated with forskolin, a nonreceptor-mediated cAMP stimulant. None of the normal or mutant forms showed any response to LH or TSH.

Conclusions: Our findings strongly indicate FSHR variants as being an intrinsic genetic cause of some forms of infertility and identify a need for functional characterization of these variants and the investigation of more individualized ovarian stimulation protocols.

Citing Articles

Serum miR-329-3p as a potential biomarker for poor ovarian response in an in vitro fertilization.

Kim J, Kim H, Lee S, Park E, Choi K, Kang K Clin Exp Reprod Med. 2025; 52(1):44-55.

PMID: 40018792 PMC: 11900665. DOI: 10.5653/cerm.2024.07094.


An update review of the application of single-cell RNA sequencing in pregnancy-related diseases.

Zhou Z, Yang X Front Endocrinol (Lausanne). 2024; 15:1415173.

PMID: 39717096 PMC: 11663665. DOI: 10.3389/fendo.2024.1415173.


Single-cell RNA-seq analysis and cell-cluster deconvolution of the human preovulatory follicular fluid cells provide insights into the pathophysiology of ovarian hyporesponse.

Roos K, Rooda I, Keif R, Liivrand M, Smolander O, Salumets A Front Endocrinol (Lausanne). 2022; 13:945347.

PMID: 36339426 PMC: 9635625. DOI: 10.3389/fendo.2022.945347.


An overview of FSH-FSHR biology and explaining the existing conundrums.

Bhartiya D, Patel H J Ovarian Res. 2021; 14(1):144.

PMID: 34717708 PMC: 8557046. DOI: 10.1186/s13048-021-00880-3.


Endogenous, tissue-resident stem/progenitor cells in gonads and bone marrow express FSHR and respond to FSH via FSHR-3.

Bhartiya D, Patel H, Kaushik A, Singh P, Sharma D J Ovarian Res. 2021; 14(1):145.

PMID: 34717703 PMC: 8556987. DOI: 10.1186/s13048-021-00883-0.


References
1.
Sprengel R, Braun T, Nikolics K, Segaloff D, Seeburg P . The testicular receptor for follicle stimulating hormone: structure and functional expression of cloned cDNA. Mol Endocrinol. 1990; 4(4):525-30. DOI: 10.1210/mend-4-4-525. View

2.
Sudo S, Kudo M, Wada S, Sato O, Hsueh A, Fujimoto S . Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod. 2002; 8(10):893-9. DOI: 10.1093/molehr/8.10.893. View

3.
Dierich A, Sairam M, Monaco L, Fimia G, Gansmuller A, Lemeur M . Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A. 1998; 95(23):13612-7. PMC: 24867. DOI: 10.1073/pnas.95.23.13612. View

4.
Lifton R, Gharavi A, Geller D . Molecular mechanisms of human hypertension. Cell. 2001; 104(4):545-56. DOI: 10.1016/s0092-8674(01)00241-0. View

5.
Layman L, Lee E, Peak D, Namnoum A, Vu K, van Lingen B . Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med. 1997; 337(9):607-11. DOI: 10.1056/NEJM199708283370905. View